ZIC2 and renal cell carcinoma: A large number of studies have shown that ZIC2 is upregulated in renal cell carcinoma [15], prostate cancer [16], oral squamous cell carcinoma [17], and bladder cancer [18], in which high expression of ZIC2 is associated with a poor prognosis.